Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
10.33
+0.09 (0.88%)
At close: Aug 1, 2025, 4:00 PM
10.29
-0.04 (-0.39%)
After-hours: Aug 1, 2025, 7:16 PM EDT

Adaptive Biotechnologies Stock Forecast

Stock Price Forecast

The 7 analysts that cover Adaptive Biotechnologies stock have a consensus rating of "Strong Buy" and an average price target of $10.57, which forecasts a 2.32% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $15.

Price Target: $10.57 (+2.32%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$6.00$10.57$10$15
Change-41.92%+2.32%-3.19%+45.21%
* Price targets were last updated on Jun 18, 2025.

Analyst Ratings

The average analyst rating for Adaptive Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy122233
Buy333333
Hold100111
Sell000000
Strong Sell000000
Total555677

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$15
Strong BuyInitiates$15+45.21%Jun 18, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$11$13
BuyMaintains$11$13+25.85%May 6, 2025
Morgan Stanley
Morgan Stanley
Hold
Maintains
$7$9
HoldMaintains$7$9-12.88%May 5, 2025
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$9$10
Strong BuyMaintains$9$10-3.19%May 2, 2025
Goldman Sachs
Goldman Sachs
Strong Buy
Upgrades
$8$9
Strong BuyUpgrades$8$9-12.88%Mar 21, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
222.60M
from 178.96M
Increased by 24.39%
Revenue Next Year
268.10M
from 222.60M
Increased by 20.44%
EPS This Year
-0.87
from -1.08
EPS Next Year
-0.65
from -0.87
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
98.38M154.34M185.31M170.28M178.96M222.60M268.10M336.65M
Revenue Growth
15.65%56.88%20.06%-8.11%5.10%24.39%20.44%25.57%
EPS
-1.11-1.48-1.40-1.56-1.08-0.87-0.65-0.37
EPS Growth
--------
Forward PE
--------
No. Analysts
-----10106
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620272028
High234.3M293.2M369.2M
Avg222.6M268.1M336.7M
Low209.4M238.6M304.0M

Revenue Growth

Revenue Growth2025202620272028
High
30.9%
31.7%
37.7%
Avg
24.4%
20.4%
25.6%
Low
17.0%
7.2%
13.4%

EPS Forecast

EPS202520262027
High-0.85-0.49-0.22
Avg-0.87-0.65-0.37
Low-0.89-0.86-0.46

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.